000 | 013180000a22003730004500 | ||
---|---|---|---|
001 | DMDOC | ||
003 | OSt | ||
005 | 20160219150156.0 | ||
006 | m | ||
008 | 160216b xxu||||| |||| 00| 0 eng d | ||
020 | _a92-9162-032-7 | ||
040 | _cNDC | ||
086 | _a01019-GG | ||
100 | _aCorrea, Carlos M., ed. | ||
245 | _aGuide to pharmaceutical patents: vol. II | ||
260 | _bSouth Centre | ||
260 | _aGeneva | ||
260 | _cJuly 2008 | ||
270 | _dSwitzerland | ||
300 | _axix 115 p. | ||
300 | _btbls. | ||
520 | _aProvides information about the patenting of pharmaceutical inventions, the concerns relating to the granting of patents or not, and the manner of determining the scope of protection. Explores the adequacy of standards to assess patent-ability requirements and the components of a patent policy. Contains notes which aim to facilitate the adoption of informed patent policies in developing countries in line with the objective of promoting access to pharmaceutical products for all. | ||
556 | _aGeneral | ||
650 | _aPharmaceuticals | ||
650 | _aPatents | ||
650 | _aWHO | ||
650 | _aPatent Law | ||
650 | _aRecommendations | ||
650 | _aPublic Health | ||
650 | _aInventions | ||
650 | _aChemicals | ||
650 | _aProducts | ||
942 |
_h08.12.06 _2NDC _cBK |
||
999 |
_c13738 _d13738 |